American TeleCare, Inc. (ATI) Appoints Michael A. Brodeur as Chief Financial Officer

American TeleCare, Inc. (ATI) Appoints Michael A. Brodeur as Chief Financial Officer

American TeleCare, the Leader in Technology-Enabled Telehealth Solutions, Adds Accomplished Financial Executive to its Senior Management Team

Minneapolis (PRWEB) February 25, 2009 -- American TeleCare, Inc. (ATI) announced that Michael A. Brodeur has joined the company as its chief financial officer. ATI is the leader in the development and application of video-based telehealth solutions to advance patient care.

"Mike is a seasoned executive with more than 25 years of high-level financial management experience in the health care, medical device, biotechnology and clinical laboratory industries," said Randy Moore, M.D., M.B.A., chairman and chief executive officer, American TeleCare (ATI). "He brings ATI exceptional expertise in corporate finance, business development and the capital markets."

"With solutions that combine telecommunications technology with unmatched clinical functionality, ATI is at the forefront of the telehealth industry," said Brodeur. "Managing the costs of caring for patients with complex, chronic conditions is a fundamental challenge in health system reform. ATI is positioned to lead the way to establish new models of telehealth-supported care that connect high-risk patients to essential clinical expertise."

Immediately before joining ATI, Brodeur was the chief financial officer of Medical CV, Inc. (NASDAQ:MDCV), developer and manufacturer of laser-based surgical devices. He has also served as CFO of McKesson Medical Management (a $500 million pharmacy outsource provider to hospitals) and Meris Laboratories, Inc. (a $50 million clinical laboratory testing company). He previously held other senior financial leadership positions with EPS Solutions Corporation and WellPoint Health Networks, Inc., now WellPoint, Inc. (NYSE:WLP), which today is the nation's largest health insurer by member numbers. Brodeur was a managing partner at Prairieview CFO Partners, LLP, a CFO services firm for public and pre-IPO emerging and middle-market businesses. And as senior partner at Tatum CFO Partners, LLP, another national CFO services firm, he served as CFO of Molecular Diagnostics, Inc., now CytoCore, Inc. (OTCBB:CYTO) and Aastrom Biosciences, Inc. (NASDAQ:ASTM).

Brodeur is a certified public accountant who began his career at Ernst & Young. He earned a bachelor's of science degree in business administration and accountancy at California State University, Long Beach, Calif.

About American TeleCare, Inc. (ATI)

Founded in 1993, American TeleCare (ATI) is the pioneer of intelligent monitoring and video-based telehealth technology. With proven experience in clinical process re-engineering, ATI works with leading healthcare organizations to put their patients at the center of care teams and supports them with best-in-class solutions. ATI systems connect continuous healing relationships and deliver essential information for clinical and self care. Ongoing monitoring and constant care of patients at home keeps them connected to clinical expertise and may help prevent acute events. The results: 100-200 percent increases in provider productivity and 65-95 percent reductions in emergency room and inpatient costs - achieved as care teams help physicians watch over, improve and maintain their patients' health. For more information, visit www.americantelecare.com. Then call 800-323-6667.

NOTE: American TeleCare will exhibit at the American Telemedicine Association (ATA) Annual International Meeting & Exposition, which will be held on April 26-28, 2009 at the Rio All-Suites Hotel and Casino, Las Vegas, Nev. American TeleCare will be at booth #300.

###

Contact Information DAVID AQUILINA

American TeleCare, Inc. (ATI)

http://www.americantelecare.com

612.922.5551

Stemedica Advances its Certification to Become a Licensed Manufacturer of Adult Stem Cells for U.S. Based Clinical Trials

Stemedica Advances its Certification to Become a Licensed Manufacturer of Adult Stem Cells for U.S. Based Clinical Trials

Stemedica Cell Technologies, Inc. announced today that it has filed with the Food and Drug Branch of the State of California's Department of Public Health for certification as a licensed manufacturer of adult stem cells for U.S.-based Phase I and Phase II Clinical Trials.

San Diego, CA (PRWEB) February 25, 2009 -- Stemedica Cell Technologies (http://www.stemedica.com), Inc. ("Stemedica") announced today that it has filed with the Food and Drug Branch of the State of California's Department of Public Health for certification as a licensed manufacturer of adult stem cells for U.S.-based Phase I and Phase II Clinical Trials. Readiness for manufacture includes obtaining a California Drug Manufacturing License for the Stemedica facility in San Diego, California.

"Completion of this certification will allow us to manufacture stem cells under contract for clinical trials for Stemedica as well as for other companies and research centers in California and across the United States. This marks a significant milestone along the journey toward the future availability of stem cell treatment for patients who so urgently need it," said Dr. Maynard Howe, Vice Chairman and CEO at Stemedica.

To prepare for inspection, Stemedica fully reconstructed its facility according to FDA requirements, which had previously focused on research and development. Stemedica's manufacturing facility now includes a fully compliant manufacturing wing with entry-level gowning rooms, two ISO class 8 sterile gowning suites, an ISO Class 7 Manufacturing Clean Room, an ISO Class 7 Processing Clean Room, a Good Manufacturing Process compliant materials warehouse and a controlled-access Quality Control testing laboratory.

"As soon as Stemedica secures its license from the State of California's Department of Public Health, we plan on filing for one or more IND's (Investigative New Drug) for specific indications with the FDA using our proprietary technology. The final major step by the Food and Drug Branch within the Department of Public Health is an in-depth, in-person inspection by their personnel. We're particularly proud of the fact that we are ready for, and capable of, seeking licensing in California, which has exceptionally stringent standards," said Dr. Alex Kharazi, Vice President, Research & Manufacturing at Stemedica.

"Becoming a Licensed Manufacturer of clinical grade adult stem cells is a significant scientific and medical step forward for the Company," said Dr. Nikolai Tankovich, Stemedica's President and Chief Medical Officer. "Securing this status will allow us to become a primary CMO (Contract Manufacturing Organization) for other for-profit companies and the many research organizations interested in advancing stem cell research through clinical application. Additionally, achieving this regulatory status within the manufacturing world will provide Stemedica with the foundation to advance its own Phase I and Phase II Clinical Studies once approved by the FDA."

About Stemedica Technologies, Inc.

Stemedica Cell Technologies Inc. (www.stemedica.com (http://www.stemedica.com)) is a specialty biopharmaceutical company that is committed to the development and manufacture of best-in-class adult stem cells for use by approved research institutions and hospitals for pre-clinical and clinical studies. Within the United States, the Company is currently developing regulatory pathways for stroke, traumatic brain injury and wound repair. Outside the United States, Stemedica provides its adult stem cells to hospitals and research centers that are conducting studies under protocols approved by the appropriate regulatory agencies. These studies are focused on the treatment of neurodegenerative disease, sight restoration and wound repair. Stemedica is based in San Diego, California.

Media Contact for Stemedica: Dave McGuigan -- dmcguigan (at) stemedica.com.

###

Contact Information Dave McGuigan

Stemedica Cell Technologies Inc

http://www.stemedica.com

+1 858 658 0910

Alternative Surface Disinfection Explored in Latest Issue of American Journal of Infection Control (AJIC)

Alternative Surface Disinfection Explored in Latest Issue of American Journal of Infection Control (AJIC)

Groundbreaking research published in the February issue of the American Journal of Infection Control validates a new surface disinfection process that may one day replace chemical disinfectants in hospitals.

Seattle WA (Vocus) February 24, 2009 -- Groundbreaking research published in the February issue of the American Journal of Infection Control (http://www.ajicjournal.org/) validates a new surface disinfection process that may one day replace chemical disinfectants in hospitals. The process incorporates a saturated steam vapor system with TANCS® technology, harnessing the power of steam to eradicate antibiotic-resistant bacteria, viruses, and fungi on surfaces in less than 5 seconds.

The study, "Reduction in Infection Risk Through Treatment of Microbially Contaminated Surfaces With a Novel, Portable, Saturated Steam Vapor Disinfection System," (http://preview.tinyurl.com/ajicjournal) was designed and overseen by Dr. Benjamin Tanner, president and scientific director of Antimicrobial Test Laboratories (http://www.antimicrobialtestlaboratories.com/). The study set out to determine the capability of the TANCS-equipped steam vapor disinfection system to kill microorganisms, reduce surface-associated infection risks and serve as an alternative to chemical disinfectants.

"During rigorous testing, the TANCS system surprised us in several instances with its efficacy," Dr. Tanner said. "It has been gratifying to see the research peer-reviewed for AJIC and to have our lab findings published in a medium easily accessible to the infection control community."

Dr. Tanner and staff treated a diverse assortment of pathogenic organisms, including vancomycin-resistant Enterococcus faecalis (VRE), methicillin-resistant Staphylococcus aureus (MRSA) and MS2 coliphage, with the TANCS system. Surface sanitation was observed within 2 seconds for most microorganisms, and all of the pathogens tested were completely inactivated within 5 seconds. Risks of infection from the contaminated surfaces clearly decreased with increasing periods of treatment.

The results confirm what Rick Hoverson, principal of Advanced Vapor Technologies (http://www.advap.com/tancs) (AVT), has seen in tests performed by other independent laboratories.

"The present level of HAIs, the ever-increasing number of multi-drug-resistant pathogens, along with concerns over use and exposure to chemicals, highlights the need for a simpler, safer, broader-spectrum and faster-acting surface disinfection protocol," Hoverson said. "This published paper represents a valid scientific basis for such a protocol."

TANCS, or Thermal Accelerated Nano Crystal Sanitation, is a patent-pending process available from AVT. According to the company, the TANCS chemical-free pre-treatment causes nano crystals to form in common tap water. When the TANCS-treated water is transformed into super-heated low-moisture steam, the crystals are energized and disrupt microbial cell walls and membranes. This, coupled with the protein denaturing effect of the moist heat, rapidly and reliably kills a broad range of pathogens.

"We are excited that this paper will create confidence and awareness in the infection prevention and environmental services sector that effective, less toxic alternatives are readily available," Hoverson said. "We believe that the more the infection control community learns about this efficacious alternative, the more the advantages will become apparent."

The American Journal of Infection Control (http://www.ajicjournal.org/) covers key topics and issues in infection control and epidemiology. Infection control professionals, including physicians, nurses, and epidemiologists, rely on AJIC for peer-reviewed articles covering clinical topics as well as original research. As the official publication of the Association for Professionals in Infection Control (APIC) and Epidemiology, Inc., AJIC is the foremost resource on infection control, epidemiology, infectious diseases, quality management, occupational health, and disease prevention.

About Advanced Vapor Technologies

Seattle-based Advanced Vapor Technologies (AVT) provides state-of-the-art steam vapor sanitation systems that enable deep cleaning and disinfection, reducing the dependence on potentially harmful or corrosive chemicals. Carrying an EPA establishment number, TANCS steam vapor units have been tested and proven to disinfect surfaces in less time and with greater safety and efficacy than typical EPA-registered chemical disinfectants. For more information, contact Rick Hoverson, principal of Advanced Vapor Technologies (http://www.advap.com/tancs), at 800-997-6584.

About Antimicrobial Test Laboratories

Antimicrobial Test Laboratories (ATL) (http://www.antimicrobialtestlaboratories.com/) is an independent testing facility specializing in the research and development of antimicrobials, including disinfectants. ATL's principal Dr. Benjamin Tanner holds a B.S. in Molecular Biology and a Ph.D. in Microbiology and Immunology from the University of Arizona, where he studied environmentally mediated disease transmission and assessed infection risks for workers.

###

Contact Information Rick Hoverson

Advanced Vapor Technologies

http://www.advap.com/tancs

800-997-6584

VerteLoc™ Now Implanted in More than 230 Patients in US / VGI Announces New Interactive Website to Support Demand

VerteLoc™ Now Implanted in More than 230 Patients in US / VGI Announces New Interactive Website to Support Demand

VG Innovations, Inc (VGI), announced today that its revolutionary VerteLoc™ Minimally Invasive Spine Stabilization system has now been implanted in more than 230 patients across the United States. A new interactive website has now been launched to support the demand for the VerteLoc™ system.

Winston-Salem, NC (PRWEB) February 23, 2009 -- VG Innovations, Inc (VGI), (www.vginnovations.com) announced today that its revolutionary VerteLoc™ Minimally Invasive Spine Stabilization system has now been implanted in more than 230 patients across the United States.

VerteLoc™ is designed to address minor spinal instabilities by effectively stabilizing the spinal facets, which are multi-directional joints of the spinal column. By addressing these indications earlier in the continuum of spine care, it may serve to reduce or eliminate back pain caused by the facet joints.

"The interest from surgeons continues to grow on a weekly basis," stated VGI's President and CEO, Dan Grayson. "VerteLoc™ is making a significant difference in the way surgeons address minor instabilities caused by various spinal diseases. Our unique patent pending allograft implant design, which combines two unique geometric shapes, and innovative directional instrumentation allows our surgeon users to replicate the VerteLoc™ procedure in a variety of surgical approaches."

A new interactive website (www.verteloc.com) has now been launched to support the demand for the VerteLoc™ system. "With the assistance of Zero Gravity Design Associates (www.zgda.com) (ZGDA), we have created an informative and educational online tool that is unlike anything currently seen in this market space," Grayson added. "Jim Olsen, and his team at ZGDA, have assisted us to raise the bar with regard to the education and training of our current and potential surgeon users and distribution partners."

The VerteLoc™ Minimally Invasive Spine Stabilization System is designed to allow earlier intervention in the continuum of spinal care. The procedure should prolong or prevent more invasive spine procedures in indicated patients, which would provide significant benefits to the quality of life versus traditional methods of spinal fusion.

Company Profile

VG Innovations, Inc, (VGI) is a privately held company and was formed in late 2007. The company is in the business of developing and commercializing proprietary, implantable devices with a specific focus on minimally invasive surgical products that could provide better surgical solutions over present technology. The products are designed to treat specific spinal disease indications that affect millions of people. More information on the company and its products can be found at: www.verteloc.com

###

Contact Information Dan Grayson

VGI

http://www.verteloc.com

336-760-2012

Reprints Desk Named to "KMWorld 100 Companies that Matter in Knowledge Management" List

Reprints Desk Named to "KMWorld 100 Companies that Matter in Knowledge Management" List

Reprints Desk, Inc., the content workflow company, today announced that the company has been named as one of "KMWorld's 100 Companies that Matter in Knowledge Management" by KMWorld Magazine.

Los Angeles, Calif. (PRWEB) February 23, 2009 -- Reprints Desk, Inc., the content workflow company (http://www.reprintsdesk.com/main/home.aspx), today announced that the company has been named as one of "KMWorld's 100 Companies that Matter in Knowledge Management" by KMWorld Magazine.

KMWorld's annual list, now in its eighth year, is compiled by knowledge management (KM) practitioners, theorists, analysts, vendors, and customers. Companies that have previously been named to the list include Google, Apple, Oracle, SAP, and EMC.

"Each company embodies as part of its culture agile and limber execution of its mission, embracing a spirit of both adaptability and innovation," said Hugh McKellar, KMWorld editor in chief.

In 2008, Reprints Desk achieved a number of accomplishments:

• Ranked first overall and in each category within the Document Delivery (http://www.reprintsdesk.com/main/docdel_overview.aspx) Best Practices and Vendor Scorecard Report published by Outsell, Inc.

• Served more than 50% of the world's top-50 pharmaceutical companies

• Launched eCTD Article Service (http://www.reprintsdesk.com/main/news.aspx) for regulatory submissions

• Established an office in Germany to support European sales

• Became a document supplier on FIZ Karlsruhe's full-text broker service FIZ AutoDoc

• Signed an agreement with the Copyright Clearance Center to integrate rights management from Rightsphere into the document delivery workflow

Reprints Desk is headquartered in Los Angeles, California, and was founded in 2006 by document delivery pioneer Peter Derycz. The company provides software services that simplify how healthcare companies and other research-oriented enterprises procure, manage, and share peerreviewed journal articles and other copyright-protected content.

About KMWorld

The leading information provider serving the Knowledge, Document and Content Management systems market, KMWorld informs more than 50,000 subscribers about the components and processes - and subsequent success stories - that together offer solutions for improving business performance. KMWorld is a publishing unit of Information Today, Inc.

About Reprints Desk ®

Reprints Desk, Inc. (www.reprintsdesk.com), is a content technology and services company that simplifies how healthcare companies and other enterprises procure, manage and share scientific journal articles and other copyright-protected content. The company's workflow solutions and end user tools help customers effectively use peer-reviewed literature in product promotions, regulatory submissions, and research. A channel supplier for more than 100 scientific, technical, and medical (STM) publishers, Reprints Desk currently serves more than half of the world's Top-50 pharmaceutical companies and earned the #1 ranking in the 2008 Document Delivery Vendor Scorecard by Outsell, Inc. Reprints Desk is a Derycz Scientific, Inc. (OTC: DYSC.PK) company. For more information about Reprints Desk, contact Ian Palmer at +1 (707) 658-1931.

Public and Media Relations Contacts:

Ian Palmer, Head of Marketing

Reprints Desk, Inc. | +1 707.658.1931

ipalmer @ reprintsdesk.com

# # #

Contact Information Ian Palmer

Reprints Desk

http://www.reprintsdesk.com

707.658.1931

KettleWorx Launches "I Love My Kettlebell" National Media Tour

KettleWorx Launches "I Love My Kettlebell" National Media Tour

Fitness expert Ryan Shanahan to promote kettlebells as the ultimate fitness tool

Minneapolis, MN (PRWEB) February 23, 2009 -- KettleWorx announced its sponsorship of Ryan Shanahan's "I Love My Kettlebell" national media tour. Shanahan, creator of KettleWorx and the world's leading expert in kettlebell fitness, will be appearing on a series of television newscasts across the country to promote awareness of kettlebells as the ultimate fitness tool.

"It's the fastest and most effective fitness and weight loss tool available, but most people still don't know what a kettlebell is, or how to use it," said Shanahan. "Once people discover how easy it is to slim down and tone up with just three, 20 minute KettleWorx sessions a week, they really will 'love their kettlebell'."

"We're seeing more interest in kettlebells as a result of recent endorsements by athletes like Lance Armstrong and celebrities like Katherine Heigl and Penelope Cruz," said Steve Roberts, CEO of FitnessWorx, LLC. "But people need expert training if they are going to get the same benefits celebrities enjoy, which is why we partnered with Ryan in the creation of KettleWorx and now support his national media tour."

Ryan Shanahan appeared yesterday on the KTVK Phoenix program "Good Morning Arizona" and today on KNSD-TV in San Diego. He has previously appeared on the CBS Early Show, on the WTXF show "Good Day Philadelphia," and on KARE 11 in Minneapolis - St. Paul. Planned future appearances include "AM Northwest" on KATU in Portland and with KING 5 in Seattle.

About Ryan Shanahan

Ryan is the world's leading kettlebell expert and the developer of KettleWorx - the most comprehensive kettlebell training program available. Over the last 20 years he's played professional hockey, represented Canada at the World Duathlon Championship, completed 22 triathlons and 2 marathons. Having trained with nothing more than a 20 pound kettlebell, Ryan recently earned 2nd place at the Heavyweight Drug Free Bodybuilding Contest.

About KettleWorx

KettleWorx is the global leader in kettlebell fitness (http://kettleworx.com/) and offers a complete kettle bell workout (http://www.kettleworx.com/) program on DVD for home use. Designed to emulate a true personal trainer experience, KettleWorx is appropriate for men and women of any fitness level. Users are led through a series of gradually more challenging workouts that comprise the "Six Week Body Transformation."

For more information, visit www.KettleWorx.com

Contact:

Jimmy Clark, President

FitnessWorx, LLC

952-443-4185

jclark (at) KettleWorx.com

###

Contact Information Jimmy Clark

FitnessWorx, LLC

http://www.KettleWorx.com

952-443-4185

Separating Fact from Bioidentical Hype

Separating Fact from Bioidentical Hype

Hot from Menopausal Symptoms and Bothered by the Media Hype about Hormone Replacement? People are hearing about bioidentical hormone replacement along with more traditional types of prescribed hormone medication from the Oprah show and other media. Lets separate Fact from Fiction. The word "bioidentical" is not an accurate medical description of this new, unregulated substance and it certainly is not exactly like the hormones the body produces otherwise there would not be a measurable and clinically evident toxic build-up in the body. In "Revitalize Your Hormones: Dr. Dale's 7 Steps to a Happier, Healthier, and Sexier You" (Wiley; May 2005), Dr. Theresa Dale offers a medically proven natural alternative to invasive and dangerous hormone replacement therapies. Dale invented the world's only clinically proven, FDA registered, homeopathic hormone rejuvenation formulas used for restoring hormone balance without side effects.

(PRWEB) February 19, 2009 -- Hot from Menopausal Symptoms and Bothered by the Media Hype about Hormone Replacement? People are hearing about bioidentical hormone replacement along with more traditional types of prescribed hormone medication from the Oprah show and other media. Lets separate Fact from Fiction. The new buzz word "bioidentical" is deceptive. It's not an accurate medical description of this new, unregulated substance and it is not exactly like the body produces. Clearly there is a measurable and clinically evident toxic build-up in the body.

Bioidentical hormone replacement is not natural even though it originates from yam or soy; it has been compounded and thus a synthetic. That's right; health providers perform thousands of before and after saliva tests on patients and it is clear that there is a toxic build up of all hormone replacement including bioidentical HRT.

Women are wary of recent warnings linking hormone replacement therapy with an increased risk for heart disease, stroke and breast cancer, more and more women are turning to alternative and natural ways to balance their hormone levels. Studies have shown that using hormones such as Prempro, Othro-Prefest or Premphase and bioidentical HRT causes the body to shut down production of its own hormones creating a dependency. Hormone replacement therapy can also elevate existing hormone levels to toxically high amounts, which can tax the adrenal glands, burden the liver, kidneys, and circulatory and immune systems.

Yet, there is a superior way to get both clinically proven and evidence based relief without being exposed to the toxic effects of ALL of these drugs. Health providers throughout the US are using FDA registered NuFem & EndoPure Homeopathic Hormone Rejuvenation, developed by Theresa Dale, ND, CCN, NP.

In "Revitalize Your Hormones: Dr. Dale's 7 Steps to a Happier, Healthier, and Sexier You" (Wiley; May 2005; $15.95/Paper), Dr. Theresa Dale offers a medically proven alternative to invasive and dangerous hormone replacement therapies. With over 20 years of experience as a Naturopathic Doctor, Certified Clinical Nutritionist and researcher, Dr. Dale has helped women balance their hormone levels through safe, non-toxic program. The world's only clinically proven homeopathic hormone rejuvenation formulas used for restoring hormone balance without side effects. These formulas actually produce healthy hormone levels in women of various ages, and eliminate symptoms such as hot flashes, mood swings, low libido, low energy and irregular menses. The formulas are FDA approved and regulated and are prepared at an FDA registered pharmacy. The remedy goes through a lengthy preparation processes. For example, an herb or substance is diluted and prepared in a manner so that just a micro amount of the original substance is left in the final formula. This method of natural preparation enhances all the properties of the herb and amplifies its efficacy. Homeopathic medicine has been used for 200 years throughout the world, and is natural without toxic side effects. See The Wellness Center website for more education about Homeopathy.

The medical establishment's approach to balancing hormones fails to embrace the concept of the body as a natural living system that is capable of self-repair. Its regimens are based on the premise that people need to look outside our bodies for hormone help via one-size-fits-all drugs. The only hormones that are safe for the human body are the ones the body makes. By using a totally natural and homeopathic program, it is possible to restore emotional, physical and sexual health by following simple and safe individualized nutritional and exercise guidelines.

For more information, call Theresa Dale's office at 866 962 6484.

Theresa Dale, ND, CCN, NP

Founder, The Wellness Center For Research & Education, Inc.

Dean, California College of Natural Medicine

www.wellnesscenter.net

###

Contact Information Theresa Dale

The Wellness Center

http://www.wellnesscenter.net

866 962 6484

Dr. Theresa Dale, ND, CCN, NP

The Wellness Center

http://www.wellnesscenter.net

805 984 7200